Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic - The Risk of Aerosol Generation during Medical Procedures

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Thompson, Katy Anne ^a   Pappachan, John V ^b   Bennett, Allan M ^a   Mittal, Himanshu ^a   Macken, Susan ^a   Dove, Brian K ^a   Nguyen Van Tam, Jonathan S ^c   Copley, Vicky R ^a   O'Brien, Sarah ^d   Hoffman, Peter ^a   Parks, Simon ^a   Bentley, Andrew ^e   Isalska, Barbara ^e   Thomson, Gail ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

2009 H1N1 INFLUENZA; AEROSOL (ATMOSPHERE); AEROSOL GENERATING PROCEDURE; AIR SAMPLING; ARTICLE; ATMOSPHERE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HOSPITAL; HUMAN; INFECTION CONTROL; INFLUENZA AEROSOL; INTENSIVE CARE; MEDICAL PROCEDURES; PROBABILITY; RESPIRATORY TRACT ASPIRATION PROCEDURE; RISK ASSESSMENT; SAMPLE SIZE; SUCTION; UNITED KINGDOM; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AEROSOLS; AGED; AIR MICROBIOLOGY; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; GREAT BRITAIN; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PANDEMICS; RESPIRATORY SYSTEM; RISK ASSESSMENT; RISK FACTORS; RNA, VIRAL; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84873908388     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056278     Document Type: Article

References (38)

1. McDonald LC, Simor AE, Su IJ, Maloney S, Ofner M, et al. (2004) SARS in healthcare facilities, Toronto and Taiwan. Emerging Infectious Diseases 10: 777-781.
2. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, et al. (2003) Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289: 2801-2809.
3. CDC (2003) Severe acute respiratory syndrome-Taiwan, 2003. MMWR Morb Mortal Wkly Rep 52: 461-466.
4. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J, (2012) Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review. PLoS ONE 7(4): e35797 doi:10.1371/journal.pone.0035797.
5. Davies A, Thomson G, Walker J, Bennett AM, (2009) A review of the risks and disease transmission associated with aerosol generating medical procedures. Journal of Infection Prevention 10: 122-126.
6. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care (2007) Available: www.who.int/csr/resources/publications/WHO_CD_EPR_2007_6/en/index.html.Accessed 2012 Jan 4.
7. Infection Prevention and control during health care for confirmed, probable or suspected cases of pandemic (H1N1) 2009 virus infection and influenza like illness (2009) Available: http://www.who.int/csr/resources/publications/swineflu/swineinfinfcont/en/index.html.Accessed 2012 Jan 4.
8. Tellier R, (2009) Aerosol transmission of influenza A virus: a review of new studies. Journal of the Royal Society/Interface 6Suppl 6: S783-790.
9. Tellier R, (2006) Review of aerosol transmission of influenza A virus. Emerging Infectious Diseases 12: 1657-1662.
10. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M, (2007) Transmission of influenza A in human beings. Lancet Infect Dis 7: 257-265.
11. Interim Guidance on Infection Control measures for 2009 H1N1 Influenza in healthcare Settings, Including Protection of Healthcare Personnel (2009) Available: http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm.Accessed 2011 Jun 24.
12. National plan "Influenza Pandemic" Nationale, S.G.D.L.D. (2009) Available: http://www.pandemie-grippale.gouv.fr/IMG/pdf/plan_PG_2009_en.pdf.Accessed 2011 Sep 12.
13. Pandemic (H1N1) 2009 Influenza- A summary of guidance for infection control in healthcare settings (2009) Available: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/dh/en/ps/documents/digitalasset/dh_110899.pdf.Accessed 2012 Jan 4.
14. Pandemic influenza: guidance for infection control in hospitals and primary care settings (2008) Available: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_084178.Accessed 2011 Sep 12.
15. Cox CS (1987) The Aerobiological Pathway of Microorganisms. Chichester: John Wiley & Sons Ltd.
16. May KR, (1966) Multistage Liquid Impinger. Bacteriol Rev 30: 559-570.
17. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, et al. (2002) Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40: 3256-3260.
18. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
19. Alford RH, Kasel JA, Lehrich JR, Knight V, (1967) Human responses to experimental infection with influenza A/Equi 2 virus. Am J Epidemiol 86: 185-192.
20. Killingley B, Greatorex J, Cauchemez S, Enstone JE, Curran M, et al. (2010) Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings. Health Technol Assess 14: 237-354.
21. Milton DK, Fabian MP, Angel M, Perez DR, McDevitt J (2010) Influenza Virus Aerosols In Human Exhaled Breath: Particle Size, Culturability, And Effect Of Surgical Masks. Am J Respir Crit Care Med 181: A6844-.
22. Lindsley WG, Blachere FM, Thewlis RE, Vishnu A, Davis KA, et al. (2010) Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 5: e15100.
23. Lindsley WG, Blachere FM, Davis KA, Pearce TA, Fisher MA, et al. (2010) Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis 50: 693-698.
24. Nicas M, Sun G, (2006) An integrated model of infection risk in a health-care environment. Risk Anal 26: 1085-1096.
25. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, et al. (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167: 775-785.
26. Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, et al. (2004) Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci U S A 101: 17383-17388.
27. Fabian P, McDevitt JJ, DeHaan WH, Fung RO, Cowling BJ, et al. (2008) Influenza virus in human exhaled breath: an observational study. PLoS One 3: e2691.
28. Fabian P, Brain J, Houseman EA, Gern J, Milton DK, (2011) Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. J Aerosol Med Pulm Drug Deliv 24: 137-147.
29. Almstrand AC, Bake B, Ljungstrom E, Larsson P, Bredberg A, et al. (2010) Effect of airway opening on production of exhaled particles. J Appl Physiol 108: 584-588.
30. Johnson GR, Morawska L, Ristovski ZD, Hargreaves M, Mengersen K, et al. (2011) Modality of human expired aerosol size distributions. Journal of Aerosol Science 42: 839-851.
31. To KK, Chan KH, Li IW, Tsang TY, Tse H, et al. (2010) Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 82: 1-7.
32. Li IW, Hung IF, To KK, Chan KH, Wong SS, et al. (2010) The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 137: 759-768.
33. Schaffer FL, Soergel ME, Straube DC, (1976) Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids. Arch Virol 51: 263-273.
34. The Influenza Pandemic Preparedness Team (2011) Routes of Transmission of the Influenza Virus- Scientific Evidence Base Review. Available: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_125332.pdf. Accessed 2013 Jan 16.
35. Soderholm SC, (1989) Proposed international conventions for particle size-selective sampling. Ann Occup Hyg 33: 301-320.
36. Hall CB, Douglas RG Jr, Geiman JM, Meagher MP, (1979) Viral shedding patterns of children with influenza B infection. J Infect Dis 140: 610-613.
37. Teunis PF, Brienen N, Kretzschmar ME, (2010) High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission. Epidemics 2: 215-222.
38. ISO/TS16976-1: 2007(E) Respiratory protective devices- Human factors- Part 1: Metabolic rates and respiratory flow rates.